Correlation between parathyroid volume and calcium and phosphorus metabolism in maintenance hemodialysis patients based on Doppler ultrasound technology
- PMID: 40374815
- DOI: 10.1007/s11255-025-04561-8
Correlation between parathyroid volume and calcium and phosphorus metabolism in maintenance hemodialysis patients based on Doppler ultrasound technology
Abstract
Objectives: To investigate the correlation between parathyroid glands (PTGs) volume and calcium and phosphorus metabolism in maintenance hemodialysis (MHD) patients with Doppler ultrasound.
Methods: MHD patients at the Hemodialysis Center of the Third Affiliated Hospital of Zunyi Medical University from January 1, 2024, to January 31, 2024, were selected as study subjects. To investigate the correlation between the number and size of PTGs detected by bedside ultrasound and indicators of calcium and phosphorus metabolism.
Results: A total of 135 patients were included, of whom 90 had explored hyperplastic PTGs and 45 did not. Correlation analysis showed a negative correlation between ultrasound total PTGs volume and with age (r = -0.222, P = 0.035), large platelet ratio (r = -0.262, P = 0.013), and mean platelet volume (r = -0.232, P = 0.028), and a positive correlation with parathyroid hormone (iPTH) (r = 0.268, P = 0.011), corrected serum calcium (r = 0.233, P = 0.027), taking cinacalcet (r = 0.252, P = 0.0.017), sevelamer carbonate (r = 0.352, P = 0.002) and compound α-ketoacid tablets (r = 0.478, P < 0.001). Multifactorial linear regression analysis showed a positive correlation between ultrasound total PTGs volume and the correlation with age (t = -3.071, 95% CI: -0.030 ~ -0.007), albumin (t = -2.242, 95% CI: -0.115 ~ -0.008), iPTH (t = 2.748, 95% CI: 0.001 ~ 0.002), corrected serum calcium (t = 2.484, 95% CI: 0.184 ~ 1.563) showed significant linear relationships.
Conclusions: A significant linear correlation was observed between PTGs volume, assessed via Doppler ultrasound, and the variables of age, albumin, iPTH, and corrected serum calcium in MHD patients. Therefore, it is essential for MHD patients to be closely monitored and have these serological indices controlled.
Keywords: Calcium and Phosphorus metabolism; Doppler ultrasound; Maintenance hemodialysis; Parathyroid gland; Secondary hyperparathyroidism (SHPT).
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare no competing interests.
Similar articles
-
Number of enlarged parathyroid glands might be a predictor of cinacalcet response in advanced secondary hyperparathyroidism.Clin Exp Nephrol. 2012 Apr;16(2):292-9. doi: 10.1007/s10157-011-0547-5. Epub 2011 Oct 20. Clin Exp Nephrol. 2012. PMID: 22011886
-
The value of clinical-ultrasonographic feature model to predict the severity of secondary hyperparathyroidism.Ren Fail. 2022 Dec;44(1):146-154. doi: 10.1080/0886022X.2022.2027784. Ren Fail. 2022. PMID: 35164637 Free PMC article.
-
[Effect of cinacalcet combined with low-dose calcitriol on clinical outcome and bone metabolism in patients with severe secondary hyperparathyroidism].Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017 Oct 28;42(10):1169-1173. doi: 10.11817/j.issn.1672-7347.2017.10.007. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2017. PMID: 29093248 Chinese.
-
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010. J Ren Nutr. 2006. PMID: 16825031 Review.
-
Risk factors for coronary artery calcification in Chinese patients undergoing maintenance hemodialysis: a meta-analysis.Int Urol Nephrol. 2025 May 2. doi: 10.1007/s11255-025-04535-w. Online ahead of print. Int Urol Nephrol. 2025. PMID: 40314886 Review.
References
-
- Rodriguez-Ortiz ME, Rodriguez M (2020) Recent advances in understanding and managing secondary hyperparathyroidism in chronic kidney disease. Faculty Rev. https://doi.org/10.12688/f1000research.22636.1
-
- Liyanage T, Ninomiya T, Jha V et al (2015) Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet 385:1975–1982. https://doi.org/10.1016/S0140-6736(14)61601-9 - DOI - PubMed
-
- Kovesdy CP (2022) Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl 12:7–11. https://doi.org/10.1016/j.kisu.2021.11.003 - DOI
-
- Tsai SH, Kan WC, Jhen RN et al (2024) Secondary hyperparathyroidism in chronic kidney disease: A narrative review focus on therapeutic strategy. Clin Med (Lond) 24:100238. https://doi.org/10.1016/j.clinme.2024.100238 - DOI - PubMed
-
- Isakova T, Cai X, Lee J et al (2020) Longitudinal evolution of markers of mineral metabolism in patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) study. Am J Kidney Dis 75:235–244. https://doi.org/10.1053/j.ajkd.2019.07.022 - DOI - PubMed
Grants and funding
- Zunyi Kehe HZ Zi [2023] No. 42/Zunyi Science and Technology Bureau, Zunyi First People's Hospital joint science and technology research and development funding program
- Zunyi Kehe HZ Zi [2023] No. 42/Zunyi Science and Technology Bureau, Zunyi First People's Hospital joint science and technology research and development funding program
- Foundation-ZK [2024] General 679/Science and Technology of Guizhou Province, Guizhou Science and Technology
LinkOut - more resources
Full Text Sources